| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc. | Director | Stock Option (right to buy) | 25K | $120K | $4.79 | 17 Jun 2025 | Direct |
| Cyclerion Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20K | 14 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | 17 Jun 2025 | 1 | $120K | 4 | Director | 17 Jun 2025, 16:28 |
| FHTX | Foghorn Therapeutics Inc. | 26 Jun 2024 | 1 | $88.3K | 4 | Director | 28 Jun 2024, 16:07 |
| FHTX | Foghorn Therapeutics Inc. | 21 Jun 2023 | 1 | $0 | 4 | Director | 22 Jun 2023, 20:10 |
| FHTX | Foghorn Therapeutics Inc. | 21 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 21:00 |
| CYCN | Cyclerion Therapeutics, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director | 16 Jun 2022, 20:56 |
| FHTX | Foghorn Therapeutics Inc. | 13 Jul 2021 | 1 | $0 | 4 | Director | 14 Jul 2021, 16:54 |
| CYCN | Cyclerion Therapeutics, Inc. | 24 Jun 2021 | 1 | $0 | 4 | Director | 28 Jun 2021, 17:14 |